Cargando…

Knockdown of UTX/KDM6A Enriches Precursor Cell Populations in Urothelial Cell Cultures and Cell Lines

The histone demethylase UTX (gene: KDM6A) directs cell and tissue differentiation during development. Deleterious mutations in KDM6A occur in many human cancers, most frequently in urothelial carcinoma. The consequences of these mutations are poorly understood; plausibly, they may disturb urothelial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lang, Alexander, Whongsiri, Patcharawalai, Yilmaz, Merve, Lautwein, Tobias, Petzsch, Patrick, Greife, Annemarie, Günes, Cagatay, Köhrer, Karl, Niegisch, Günter, Hoffmann, Michèle, Schulz, Wolfgang A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226239/ https://www.ncbi.nlm.nih.gov/pubmed/32326336 http://dx.doi.org/10.3390/cancers12041023

Ejemplares similares

Contingencies of UTX/KDM6A Action in Urothelial Carcinoma
por: Lang, Alexander, et al.
Publicado: (2019)

Many Different LINE-1 Retroelements Are Activated in Bladder Cancer
por: Whongsiri, Patcharawalai, et al.
Publicado: (2020)

Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1
por: Wang, Chenyin, et al.
Publicado: (2020)

Proteomic and transcriptomic profiles of human urothelial cancer cells with histone deacetylase 5 overexpression
por: Jaguva Vasudevan, Ananda Ayyappan, et al.
Publicado: (2022)

Concomitant downregulation of the imprinted genes DLK1 and MEG3 at 14q32.2 by epigenetic mechanisms in urothelial carcinoma
por: Greife, Annemarie, et al.
Publicado: (2014)

Canonical Notch signalling is inactive in urothelial carcinoma
por: Greife, Annemarie, et al.
Publicado: (2014)

Multiple Mechanisms Mediate Resistance to Sorafenib in Urothelial Cancer
por: Knievel, Judith, et al.
Publicado: (2014)

KDM6A mutations promote acute cytoplasmic DNA release, DNA damage response and mitosis defects
por: Koch, J., et al.
Publicado: (2021)

Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines
por: Skowron, Margaretha A., et al.
Publicado: (2019)

HDAC5 Expression in Urothelial Carcinoma Cell Lines Inhibits Long-Term Proliferation but Can Promote Epithelial-to-Mesenchymal Transition
por: Jaguva Vasudevan, Ananda Ayyappan, et al.
Publicado: (2019)

SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade
por: Romero, Octavio A., et al.
Publicado: (2021)

UTX/KDM6A suppresses AP-1 and a gliogenesis program during neural differentiation of human pluripotent stem cells
por: Xu, Beisi, et al.
Publicado: (2020)

Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells
por: Grunewald, Camilla M., et al.
Publicado: (2021)

Metformin directly targets the H3K27me3 demethylase KDM6A/UTX
por: Cuyàs, Elisabet, et al.
Publicado: (2018)

UTX/KDM6A Deletion Promotes Recovery of Spinal Cord Injury by Epigenetically Regulating Vascular Regeneration
por: Ni, Shuangfei, et al.
Publicado: (2019)

HERV-K and LINE-1 DNA Methylation and Reexpression in Urothelial Carcinoma
por: Kreimer, Ulrike, et al.
Publicado: (2013)

UTX/KDM6A deletion promotes the recovery of spinal cord injury by epigenetically triggering intrinsic neural regeneration
por: Guo, Zhu, et al.
Publicado: (2020)

Epigenetic modifier Kdm6a/Utx controls the specification of hypothalamic neuronal subtypes in a sex-dependent manner
por: Cabrera Zapata, Lucas E., et al.
Publicado: (2022)

Predicting immune checkpoint inhibitor response in urothelial carcinoma: another step in personalised medicine?
por: Niegisch, Günter
Publicado: (2019)

Alternative mRNA Splicing Controls the Functions of the Histone H3K27 Demethylase UTX/KDM6A
por: Fotouhi, Omid, et al.
Publicado: (2023)

Insulin-Like Growth Factor 1 Attenuates the Pro-Inflammatory Phenotype of Neutrophils in Myocardial Infarction
por: Nederlof, Rianne, et al.
Publicado: (2022)

Target sequencing and CRISPR/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer
por: Ahn, Jinwoo, et al.
Publicado: (2016)

Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment
por: Lehmann, Maria, et al.
Publicado: (2014)

A KDM6 inhibitor potently induces ATF4 and its target gene expression through HRI activation and by UTX inhibition
por: Kitajima, Shojiro, et al.
Publicado: (2021)

The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism
por: Chang, Soojeong, et al.
Publicado: (2019)

Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines
por: Hölscher, Alexander S., et al.
Publicado: (2018)

The Prognostic Significance of Histone Demethylase UTX in Esophageal Squamous Cell Carcinoma
por: Li, Shau-Hsuan, et al.
Publicado: (2018)

Distinct mechanisms contribute to acquired cisplatin resistance of urothelial carcinoma cells
por: Höhn, Annika, et al.
Publicado: (2016)

Epigenetic Treatment of Urothelial Carcinoma Cells Sensitizes to Cisplatin Chemotherapy and PARP Inhibitor Treatment
por: Thy, Sophia, et al.
Publicado: (2021)

Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines
por: Pinkerneil, Maria, et al.
Publicado: (2016)

UTX promotes CD8(+) T cell-mediated antiviral defenses but reduces T cell durability
por: Mitchell, Joseph E., et al.
Publicado: (2021)

Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine
por: Isono, Makoto, et al.
Publicado: (2017)

The histone demethylase UTX regulates the lineage-specific epigenetic program of invariant natural killer T cells
por: Beyaz, Semir, et al.
Publicado: (2016)

UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma
por: Li, Xiaoxi, et al.
Publicado: (2018)

UTX Affects Neural Stem Cell Proliferation and Differentiation through PTEN Signaling
por: Lei, Xuepei, et al.
Publicado: (2018)

Histone demethylases UTX and JMJD3 are required for NKT cell development in mice
por: Northrup, Daniel, et al.
Publicado: (2017)

Knockdown of KDM5B Leads to DNA Damage and Cell Cycle Arrest in Granulosa Cells via MTF1
por: Yang, Yingnan, et al.
Publicado: (2023)

The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells
por: Heubach, Judith, et al.
Publicado: (2015)

Effects of novel HDAC inhibitors on urothelial carcinoma cells
por: Kaletsch, Aline, et al.
Publicado: (2018)

Inhibition of UTX/KDM6A improves recovery of spinal cord injury by attenuating BSCB permeability and macrophage infiltration through the MLCK/p-MLC pathway
por: Xie, Yong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oa31paq45u5uenr28m0aceecej